1-20 of 56
Hannes Wandt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma- Retrospective Analysis of 2 Randomized Trials of the German Low Grade Lymphoma Study Group ( GLSG )

Vindi Jurinovic, M.Sc., Bernd Metzner, MD, PhD, Michael Pfreundschuh, MD, PhD, Norbert Schmitz, MD, PhD, Hannes Wandt, MD, PhD, Christian Peschel, MD, PhD, Martin Dreyling, MD PhD, Wolfgang Hiddemann, MD, PhD, Eva Hoster, PhD, Michael Unterhalt, PhD, Oliver Weigert, MD
Journal: Blood
Blood (2016) 128 (22): 3464.
https://doi.org/10.1182/blood.V128.22.3464.3464
Published: 2016
Journal Articles

Bortezomib Consolidation Following Autologous Transplant Equalizes the Outcome for Older Patients with Less Intensive Pretreatment Compared to Younger Patients with Newly Diagnosed Multiple Myeloma

Christian Straka, MD, Stefan Knop, MD, Martin Vogel, MD PhD, Jurgen Müller, Dipl. Stat., Martin Kropff, MD, Bernd Metzner, MD, Christian Langer, MD, Herbert Sayer, MD, Wolfram Jung, MD, Heinz Dürk, MD PhD, Hans-Juergen Salwender, MD, Hannes Wandt, MD, PhD, Florian Bassermann, MD, Martin Gramatzki, MD, Wolf Rösler, MD, Hans-Heinrich Wolf, MD, Wolfram Brugger, MD PhD, Monika Engelhardt, MD, Thomas Fischer, MD, Peter Liebisch, MD, Hermann Einsele, MD
Journal: Blood
Blood (2016) 128 (22): 516.
https://doi.org/10.1182/blood.V128.22.516.516
Published: 2016
Journal Articles

Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma

Stefan Knop, MD, Peter Liebisch, MD, Holger Hebart, MD, Ernst Holler, MD, Monika Engelhardt, MD, Bernd Metzner, MD, Dietrich Peest, MD, Walter Aulitzky, MD, Donald W. Bunjes, MD, Christian Straka, MD, Thomas Fischer, MD, Hannes Wandt, MD, Orhan Sezer, MD, Markus Hentrich, MD, Helmut Ostermann, MD, Christian Peschel, MD, Georg Hess, MD, Bernd Hertenstein, MD, Mathias Freund, MD, Martin H Kropff, MD, Hans-Heinrich Wolf, MD, Wolfram E Jung, MD, Norbert Frickhofen, MD, Ralf C. Bargou, Georg Maschmeyer, MD, Else Heidemann, MD, Christian Langer, MD, Lothar Kanz, MD, Christoph Meisner, PhD, Hermann Einsele, MD
Journal: Blood
Blood (2014) 124 (21): 43.
https://doi.org/10.1182/blood.V124.21.43.43
Published: 2014
Journal Articles

Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma

Christian Straka, MD, Kerstin Schaefer-Eckart, MD, Florian Bassermann, MD, Hansen Timon, MD, Bernd Hertenstein, MD, Christian Langer, MD, Hans Salwender, MD, Stefan Knop, MD, Monika Engelhardt, MD, Martin Kropff, MD, Wolf Roesler, MD, Thomas Decker, MD, Holger Hebart, MD, Norbert Frickhofen, MD, Albrecht Reichle, Christian Gerecke, MD, Bernd Metzner, Else Heidemann, MD, Tim H Brummendorf, MD, Juliane Ababei, MD, Wolfram E Jung, MD, Martin Gramatzki, MD, Marcus Hentrich, MD, Peter Bojko, MD, Ivana von Metzler, MD, Martin Kaufmann, MD, Ralph Naumann, MD, Thomas Kubin, MD, Burkhard Schmidt, MD, Jochem Walther, MD, Tobias Dechow, MD, Hannes Wandt, MD, Brigitte Schnabel, Axel Hinke, PhD, Hermann Einsele
Journal: Blood
Blood (2014) 124 (21): 3969.
https://doi.org/10.1182/blood.V124.21.3969.3969
Published: 2014
Journal Articles

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Bettina Pilz, Michael Kramer, PhD, Gerhard Ehninger, MD, Martin Wilhelm, MD PhD, Hannes Wandt, MD
Journal: Blood
Blood (2014) 124 (21): 3686.
https://doi.org/10.1182/blood.V124.21.3686.3686
Published: 2014
Journal Articles

Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients

Christian Straka, Kerstin Schäfer-Eckart, Florian Bassermann, Bernd Hertenstein, Monika Engelhardt, Hans Salwender, MD, Wolf Rösler, Christian Langer, Georgia Schilling, Stefan Knop, Tim H Brümmendorf, Bernd Metzner, Holger Hebart, Albrecht Reichle, Norbert Frickhofen, MD, Else Heidemann, Juliana Ababei, Christian Gerecke, Wolfram Jung, Martin Gramatzki, Thomas Decker, Martin Kropff, MD, Ralph Naumann, Marcus Hentrich, Jochem Walther, Peter Bojko, Tobias Dechow, Hannes Wandt, Axel Hinke, Hermann Einsele
Journal: Blood
Blood (2012) 120 (21): 2012.
https://doi.org/10.1182/blood.V120.21.2012.2012
Published: 2012
Journal Articles

No Benefit of Combining Additional Compounds with Standard High Dose Cytarabine Consolidation: Results of the Prospective Randomized AML2003 Study

Stefani Parmentier, MD, Martin Bornhäuser, MD, Prof., Christian Thiede, MD, Christoph Röllig, MD, Michael Kramer, Mathias Haenel, MD, Regina Herbst, MD, Norbert Schmitz, MD, Prof., Reingard Stuhlmann, MD, Hannes Wandt, Kerstin Schäfer-Eckart, MD, Walter E. Aulitzky, Martin Kaufmann, MD, Anthony D. Ho, Alwin Krämer, MD, Wolfgang E. Berdel, Carsten Müller-Tidow, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Markus Schaich, MD
Journal: Blood
Blood (2011) 118 (21): 255.
https://doi.org/10.1182/blood.V118.21.255.255
Published: 2011
Journal Articles

RAD (Lenalidomide, Adriamycin and Dexamethasone) Is a Novel and Very Effective Induction Regimen in Newly Diagnosed Multiple Myeloma Preceding a Risk-Adjusted Transplant Strategy,

Stefan Knop, MD, Christian Langer, MD, Monika Engelhardt, MD, Lars O Muegge, MD, Christoph Röllig, Albrecht Reichle, MD, Martin Gramatzki, Wolf Rösler, MD, Hannes Wandt, MD, Bernd Hertenstein, MD, Susanne Höppner, MD, Helmut Ostermann, MD, Isrid Sturm, MD, Tobias Dechow, MD, Mark Ringhoffer, MD, Marianne Sauerwein, MD, Hermann Einsele, MD, Ralf Bargou, MD
Journal: Blood
Blood (2011) 118 (21): 3967.
https://doi.org/10.1182/blood.V118.21.3967.3967
Published: 2011
Journal Articles

Two Cycles of Risk-Adapted Consolidation Leads to a Favorable Long-Term Prognosis in Patients with Acute Promyelocytic Leukemia After Standard AIDA Induction: Results From 141 Patients Treated in the SAL-AIDA-2000 Trial

Uwe Platzbecker, MD, Ulrich Schuler, Martin Bornhäuser, Michael Kramer, Markus Schaich, MD, Uta Oelschlagel, Brigitte Mohr, Mathias Hänel, Hannes Wandt, Thomas Wagner, Hermann Einsele, Stefan W. Krause, MD, Heinrich Bodenstein, Walter E. Aulitzky, Norbert Schmitz, Anthony D. Ho, Gerhard Ehninger, MD, Christoph Röllig, MD
Journal: Blood
Blood (2011) 118 (21): 765.
https://doi.org/10.1182/blood.V118.21.765.765
Published: 2011
Journal Articles

A Strong Immune Effect by Allogeneic Stem Cell Transplantation May Improve Survival in AML Patients with a High Ratio of the FLT3-ITD Mutation to the Wt-FLT3 Allele: Results from an Analysis of 257 Patients Treated in the SAL AML-2003 Trial

Gerhard Ehninger, MD, Martin Bornhauser, Michael Kramer, Christoph Röllig, MD, Hannes Wandt, Mathias Hanel, Hermann Einsele, MD, Walter E. Aulitzky, Norbert Schmitz, Wolfgang E. Berdel, Matthias Stelljes, Joachim Kienast, Eckhard Thiel, Andreas Mackensen, Uwe Platzbecker, MD, Markus Schaich, MD, Johannes Schetelig, Jiri Mayer, MD, Hubert Serve, MD, Anthony D. Ho, Christian Thiede, MD
Journal: Blood
Blood (2011) 118 (21): 497.
https://doi.org/10.1182/blood.V118.21.497.497
Published: 2011
Journal Articles

A Multicenter Retrospective Analysis on Pentostatin As Salvage Therapy of Severe Steroid Refractory Intestinal Acute Graft Versus Host Disease

Stefan A. Klein, Thomas Schmitt, Gesine Bug, Johannes Schetelig, Rainer Schwerdtfeger, Kerstin Schaefer-Eckart, Christoph Schmid, Hannes Wandt, Wolf-Karsten Hofmann, Martin Bornhaeuser, Hans Martin, Peter Dreger
Journal: Blood
Blood (2011) 118 (21): 3048.
https://doi.org/10.1182/blood.V118.21.3048.3048
Published: 2011
Journal Articles

Prolonged Remission Duration with Interferon Maintenance After Rituximab-Containing Induction in First-Line Advanced Stage Lymphoplasmacytic Lymphoma – a Retrospective Analysis of the German Low-Grade Lymphoma Study Group (GLSG)

Eva Hoster, Dr., Michael Unterhalt, Dr., Bernd Metzner, Michael Pfreundschuh, MD, Peter Staib, Georg Jacobs, Hans Walter Lindemann, Wolf-Dieter Ludwig, H. Tilman Steinmetz, Lorenz Truemper, Hannes Wandt, Christian Buske, Martin H. Dreyling, PhD, Wolfgang Hiddemann, PhD
Journal: Blood
Blood (2011) 118 (21): 1639.
https://doi.org/10.1182/blood.V118.21.1639.1639
Published: 2011
Journal Articles

Allogeneic Stem Cell Transplantation Confers a Favorable Outcome in Patients with NPM1 Positive Acute Myeloid Leukemia: Results From a Donor Vs. No-Donor Analysis of 309 Patients Treated in the SAL AML-2003 Trial

Christoph Röllig, Martin Bornhäuser, Christian Thiede, MD, Michael Kramer, Anthony Ho, Hannes Wandt, Mathias Hänel, Hermann Einsele, MD, Walter E. Aulitzky, Norbert Schmitz, Wolfgang E. Berdel, Matthias Stelljes, Joachim Kienast, Eckhard Thiel, Stefan W. Krause, MD, Friedrich Stölzel, MD, Uwe Platzbecker, MD, Markus Schaich, Johannes Schetelig, Gerhard Ehninger, MD
Journal: Blood
Blood (2011) 118 (21): 493.
https://doi.org/10.1182/blood.V118.21.493.493
Published: 2011
Journal Articles

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Clinical Trials & Observations
Christian Straka, Michael Sandherr, Hans Salwender, Hannes Wandt, Bernd Metzner, Kai Hübel, Gerda Silling, Marcus Hentrich, Daniel Franke, Rainer Schwerdtfeger, Mathias Freund, Orhan Sezer, Alexander Giagounidis, Gerhard Ehninger, Wolfgang Grimminger, Andreas Engert, Günter Schlimok, Christof Scheid, Peter Hellmann, Harald Heinisch, Hermann Einsele, Axel Hinke, Bertold Emmerich
Journal: Blood
Blood (2011) 117 (7): 2121–2128.
https://doi.org/10.1182/blood-2010-06-290080
Published: 2011
Journal Articles

Sorafenib In Combination with Standard Induction and Consolidation Therapy In Elderly AML Patients: Results From a Randomized, Placebo-Controlled Phase II Trial

Hubert Serve, Ruth Wagner, Cristina Sauerland, Uta Brunnberg, Utz Krug, Markus Schaich, Oliver G. Ottmann, Justus Duyster, Hannes Wandt, Wolfgang Herr, Aristoteles A.N. Giagounidis, Andreas Neubauer, Albrecht Reichle, Walter E. Aulitzky, Richard Noppeney, Igor Wolfgang Blau, Volker Kunzmann, Norbert Schmitz, Karl-Anton Kreuzer, Alwin Krämer, Christian Brandts, Björn Steffen, Achim Heinecke, Christian Thiede, Carsten Müller-Tidow, Gerhard Ehninger, Wolfgang E. Berdel
Journal: Blood
Blood (2010) 116 (21): 333.
https://doi.org/10.1182/blood.V116.21.333.333
Published: 2010
Journal Articles

Induction Treatment In Elderly Patients with Acute Myeloid Leukemia (AML): Randomized Comparison of Intermediate-Dose Cytarabine Plus Mitoxantrone (IMA) Versus Standard-Dose Cytarabine Plus Daunorubicin (DA) In 492 AML Patients >60 Years – Results From the SAL 60plus Trial

Christoph Röllig, Michael Kramer, Mathias Hanel, MD, Regina Herbst, Norbert Schmitz, MD, Heinrich Bodenstein, Karl-Heinz Pflüger, Thomas Wagner, Martin Wolf, MD, Martin Bornhäuser, Christian Thiede, MD, Markus Schaich, MD, Uwe Platzbecker, Friedrich Stölzel, MD, Malte von Bonin, Hannes Wandt, MD, Gerhard Ehninger, Ulrich Schuler
Journal: Blood
Blood (2010) 116 (21): 334.
https://doi.org/10.1182/blood.V116.21.334.334
Published: 2010
Journal Articles

Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Is Superior to 6 Courses CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT In Mantle Cell Lymphoma: Results of the MCL Younger Trial of the European Mantle Cell Lymphoma Network ( MCL net )

Olivier Hermine, MD, PhD, Eva Hoster, Jan Walewski, Vincent Ribrag, MD, Nicole Brousse, Catherine Thieblemont, MD, Reda Bouabdallah, Stephan Stilgenbauer, M.D., Pierre Feugier, MD, PhD, Roswitha Forstpointner, MD, Corinne Haioun, MD, Michael Kneba, MD, PhD, Mathias Hänel, Rene-Olivier Casasnovas, MD, Jürgen Finke, MD, Michael Hallek, MD, Hannes Wandt, MD, Andre Bosly, MD, Wolfram Klapper, MD, Christian Gisselbrecht, MD, Bertrand Coiffier, MD, PhD, Wolfgang Hiddemann, MD, PhD, Michael Unterhalt, MD, PhD, Martin H. Dreyling, MD
Journal: Blood
Blood (2010) 116 (21): 110.
https://doi.org/10.1182/blood.V116.21.110.110
Published: 2010
Journal Articles

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Clinical Trials & Observations
Christoph Röllig, Christian Thiede, Martin Gramatzki, Walter Aulitzky, Heinrich Bodenstein, Martin Bornhäuser, Uwe Platzbecker, Reingard Stuhlmann, Ulrich Schuler, Silke Soucek, Michael Kramer, Brigitte Mohr, Uta Oelschlaegel, Friedrich Stölzel, Malte von Bonin, Martin Wermke, Hannes Wandt, Gerhard Ehninger, Markus Schaich, for the Study Alliance Leukemia
Journal: Blood
Blood (2010) 116 (6): 971–978.
https://doi.org/10.1182/blood-2010-01-267302
Published: 2010
Journal Articles

WHO classification of myeloid neoplasms and leukemia

Hannes Wandt, Torsten Haferlach, Christian Thiede, Gerhard Ehninger
Journal: Blood
Blood (2010) 115 (3): 748–749.
https://doi.org/10.1182/blood-2009-10-249664
Published: 2010
Journal Articles

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Clinical Trials & Observations
Nicolaus Kröger, Ernst Holler, Guido Kobbe, Martin Bornhäuser, Rainer Schwerdtfeger, Herrad Baurmann, Arnon Nagler, Wolfgang Bethge, Matthias Stelljes, Lutz Uharek, Hannes Wandt, Andreas Burchert, Paolo Corradini, Jörg Schubert, Martin Kaufmann, Peter Dreger, Gerald G. Wulf, Hermann Einsele, Tatjana Zabelina, Hans Michael Kvasnicka, Jürgen Thiele, Ronald Brand, Axel R. Zander, Dietger Niederwieser, Theo M. de Witte
Journal: Blood
Blood (2009) 114 (26): 5264–5270.
https://doi.org/10.1182/blood-2009-07-234880
Published: 2009